According to PDS Biotechnology
's latest financial reports the company has $56.56 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $73.82 M | 13.15% |
2021-12-31 | $65.24 M | 126.23% |
2020-12-31 | $28.83 M | 137.13% |
2019-12-31 | $12.16 M | -64.9% |
2018-12-31 | $34.64 M | -60.66% |
2017-12-31 | $88.06 M | -17.23% |
2016-12-31 | $0.10 B | -18.27% |
2015-12-31 | $0.13 B | 848.28% |
2014-12-31 | $13.72 M | 74.71% |
2013-12-31 | $7.85 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 268.08% | ๐บ๐ธ USA |